Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 156 | 287 | 103 | 0 | 0 |
| Gross Profit | 156 | 287 | 103 | N/A | N/A |
| Operating Expenses | 2,620 | 2,849 | 3,327 | 3,669 | 3,537 |
| Operating Income | -2,463 | -2,562 | -3,223 | -3,669 | -3,537 |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | 11 | 506 | 12 | 20 | -65 |
| Pre-tax Income | -2,453 | -2,056 | -3,212 | -3,649 | -3,602 |
| Net Income Continuous | -2,453 | -2,056 | -3,212 | -3,649 | -3,602 |
| Net Income | $-2,453 | $-2,056 | $-3,212 | $-3,649 | $-3,602 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.07 | -0.08 | -0.07 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.07 | -0.08 | -0.08 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.07 | -0.08 | -0.07 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.07 | -0.08 | -0.08 |
| EBITDA(a) | $-2,428 | $-2,525 | $-3,159 | $-3,609 | $-3,511 |